During a 2021 earnings call with stockholders, Pfizer Chief Financial Officer Frank D’Amelio discussed how the company was using “pandemic pricing” to charge $19.50 per COVID-19 vaccine dose, a product it expected to make $15 billion on in 2021.

“[There’s] significant opportunity for those margins to improve once we get beyond the pandemic environment that we’re in,” D’Amelio said.

He wasn’t joking.

When the Associated Press rolled out a story a couple weeks ago announcing that Americans can now receive an updated COVID shot, buried in the twelfth paragraph was this little nugget.

“The list price of a dose of each shot is $120 to $130, according to the manufacturers,” the AP reported.

Posted in

Iron Will

Leave a Comment

You must be logged in to post a comment.